bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.3% – Time to Sell?

Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW) dropped 15.3% on Monday . The stock traded as low as $0.2203 and last traded at $0.2203. Approximately 800 shares changed hands during trading, a decline of 24% from the average daily volume of 1,054 shares. The stock had previously closed at $0.2602.

bioAffinity Technologies Stock Down 15.3%

The stock has a fifty day moving average of $0.29 and a 200-day moving average of $0.28.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.